US Stock MarketDetailed Quotes

Actuate Therapeutics (ACTU)

Watchlist
  • 2.270
  • -0.050-2.16%
Close Mar 26 16:00 ET
  • 2.270
  • 0.0000.00%
Pre 04:59 ET
53.82MMarket Cap-2.14P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Actuate Therapeutics (ACTU) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-10.59%22.5M
-28.52%4.69M
1.47%5.47M
9.81%5.97M
-18.11%6.37M
0.75%25.16M
-13.87%6.56M
-16.72%5.39M
-2.67%5.44M
46.71%7.77M
Selling and administrative expenses
88.18%12.2M
-10.94%2.56M
101.40%3.29M
201.52%3.2M
244.56%3.15M
98.57%6.48M
196.40%2.87M
129.05%1.64M
31.65%1.06M
17.81%912.82K
-General and administrative expense
88.18%12.2M
-10.94%2.56M
101.40%3.29M
201.52%3.2M
244.56%3.15M
98.57%6.48M
196.40%2.87M
129.05%1.64M
31.65%1.06M
17.81%912.82K
Research and development costs
-44.89%10.29M
-42.22%2.13M
-42.03%2.18M
-36.77%2.76M
-53.06%3.22M
-13.97%18.68M
-44.54%3.69M
-34.79%3.76M
-8.47%4.37M
51.65%6.86M
Operating profit
10.59%-22.5M
28.52%-4.69M
-1.47%-5.47M
-9.81%-5.97M
18.11%-6.37M
-0.75%-25.16M
13.87%-6.56M
16.72%-5.39M
2.67%-5.44M
-46.71%-7.77M
Net non-operating interest income expense
31.38%267.46K
19.00%134.52K
-15.99%64.91K
445.59%19.47K
400.10%48.56K
-34.12%203.58K
106.94%113.04K
-36.09%77.26K
-96.77%3.57K
-58.14%9.71K
Non-operating interest income
29.43%287.71K
18.17%139.58K
-13.35%69.97K
183.79%24.53K
262.66%53.62K
-36.97%222.29K
97.89%118.12K
-35.89%80.75K
-92.51%8.65K
-71.37%14.79K
Non-operating interest expense
8.19%20.25K
-0.28%5.06K
45.11%5.06K
-0.28%5.06K
-0.26%5.06K
-57.11%18.72K
0.26%5.08K
-31.07%3.49K
0.28%5.08K
-82.16%5.08K
Other net income (expense)
-2,816.70%-2.33M
0
-3,985.43%-655.32K
-2,171.86%-1.14M
-10,533.29%-532.52K
Gain on sale of security
----
----
----
----
----
431.16%264.34K
--0
3,085.05%537.19K
-378.82%-240.34K
-737.05%-32.52K
Other non- operating income (expenses)
----
----
----
----
----
---2.59M
--0
---1.19M
---900K
---500K
Income before tax
18.54%-22.23M
29.35%-4.55M
9.44%-5.41M
9.48%-5.95M
23.86%-6.32M
-10.27%-27.29M
15.32%-6.45M
5.79%-5.97M
-18.97%-6.57M
-57.41%-8.3M
Income tax
Net income
18.54%-22.23M
29.35%-4.55M
9.44%-5.41M
9.48%-5.95M
23.86%-6.32M
-10.27%-27.29M
15.32%-6.45M
5.79%-5.97M
-18.97%-6.57M
-57.41%-8.3M
Net income continuous Operations
18.54%-22.23M
29.35%-4.55M
9.44%-5.41M
9.48%-5.95M
23.86%-6.32M
-10.27%-27.29M
15.32%-6.45M
5.79%-5.97M
-18.97%-6.57M
-57.41%-8.3M
Minority interest income
Net income attributable to the parent company
18.54%-22.23M
29.35%-4.55M
9.44%-5.41M
9.48%-5.95M
23.86%-6.32M
-10.27%-27.29M
15.32%-6.45M
5.79%-5.97M
-18.97%-6.57M
-57.41%-8.3M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
18.54%-22.23M
29.35%-4.55M
9.44%-5.41M
9.48%-5.95M
23.86%-6.32M
-10.27%-27.29M
15.32%-6.45M
5.79%-5.97M
-18.97%-6.57M
-57.41%-8.3M
Basic earnings per share
67.48%-1.06
45.46%-0.18
54.55%-0.25
12.76%-0.3
26.28%-0.32
-151.79%-3.26
17.14%-0.33
-34.42%-0.55
3.58%-0.3439
-27.58%-0.4341
Diluted earnings per share
67.48%-1.06
45.46%-0.18
54.55%-0.25
12.76%-0.3
26.28%-0.32
-151.79%-3.26
17.14%-0.33
-34.42%-0.55
3.58%-0.3439
-27.58%-0.4341
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -10.59%22.5M-28.52%4.69M1.47%5.47M9.81%5.97M-18.11%6.37M0.75%25.16M-13.87%6.56M-16.72%5.39M-2.67%5.44M46.71%7.77M
Selling and administrative expenses 88.18%12.2M-10.94%2.56M101.40%3.29M201.52%3.2M244.56%3.15M98.57%6.48M196.40%2.87M129.05%1.64M31.65%1.06M17.81%912.82K
-General and administrative expense 88.18%12.2M-10.94%2.56M101.40%3.29M201.52%3.2M244.56%3.15M98.57%6.48M196.40%2.87M129.05%1.64M31.65%1.06M17.81%912.82K
Research and development costs -44.89%10.29M-42.22%2.13M-42.03%2.18M-36.77%2.76M-53.06%3.22M-13.97%18.68M-44.54%3.69M-34.79%3.76M-8.47%4.37M51.65%6.86M
Operating profit 10.59%-22.5M28.52%-4.69M-1.47%-5.47M-9.81%-5.97M18.11%-6.37M-0.75%-25.16M13.87%-6.56M16.72%-5.39M2.67%-5.44M-46.71%-7.77M
Net non-operating interest income expense 31.38%267.46K19.00%134.52K-15.99%64.91K445.59%19.47K400.10%48.56K-34.12%203.58K106.94%113.04K-36.09%77.26K-96.77%3.57K-58.14%9.71K
Non-operating interest income 29.43%287.71K18.17%139.58K-13.35%69.97K183.79%24.53K262.66%53.62K-36.97%222.29K97.89%118.12K-35.89%80.75K-92.51%8.65K-71.37%14.79K
Non-operating interest expense 8.19%20.25K-0.28%5.06K45.11%5.06K-0.28%5.06K-0.26%5.06K-57.11%18.72K0.26%5.08K-31.07%3.49K0.28%5.08K-82.16%5.08K
Other net income (expense) -2,816.70%-2.33M0-3,985.43%-655.32K-2,171.86%-1.14M-10,533.29%-532.52K
Gain on sale of security --------------------431.16%264.34K--03,085.05%537.19K-378.82%-240.34K-737.05%-32.52K
Other non- operating income (expenses) -----------------------2.59M--0---1.19M---900K---500K
Income before tax 18.54%-22.23M29.35%-4.55M9.44%-5.41M9.48%-5.95M23.86%-6.32M-10.27%-27.29M15.32%-6.45M5.79%-5.97M-18.97%-6.57M-57.41%-8.3M
Income tax
Net income 18.54%-22.23M29.35%-4.55M9.44%-5.41M9.48%-5.95M23.86%-6.32M-10.27%-27.29M15.32%-6.45M5.79%-5.97M-18.97%-6.57M-57.41%-8.3M
Net income continuous Operations 18.54%-22.23M29.35%-4.55M9.44%-5.41M9.48%-5.95M23.86%-6.32M-10.27%-27.29M15.32%-6.45M5.79%-5.97M-18.97%-6.57M-57.41%-8.3M
Minority interest income
Net income attributable to the parent company 18.54%-22.23M29.35%-4.55M9.44%-5.41M9.48%-5.95M23.86%-6.32M-10.27%-27.29M15.32%-6.45M5.79%-5.97M-18.97%-6.57M-57.41%-8.3M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 18.54%-22.23M29.35%-4.55M9.44%-5.41M9.48%-5.95M23.86%-6.32M-10.27%-27.29M15.32%-6.45M5.79%-5.97M-18.97%-6.57M-57.41%-8.3M
Basic earnings per share 67.48%-1.0645.46%-0.1854.55%-0.2512.76%-0.326.28%-0.32-151.79%-3.2617.14%-0.33-34.42%-0.553.58%-0.3439-27.58%-0.4341
Diluted earnings per share 67.48%-1.0645.46%-0.1854.55%-0.2512.76%-0.326.28%-0.32-151.79%-3.2617.14%-0.33-34.42%-0.553.58%-0.3439-27.58%-0.4341
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +67.21%
Sample Name
Sample Code
 +49.51%
Sample Name
Sample Code
 +47.00%
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+46.30%
5
United States Gasoline Fund Lp
UGA
+37.41%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +4.14%
Sample Name
Sample Code
 +3.52%
Sample Name
Sample Code
 +3.27%
4
Li Auto
LI
+2.81%
5
Kanzhun
BZ
+1.12%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the prospect of a ceasefire negotiation between the US and Iran has been dominating market sentiment. On March 26 EST, President T Show More
Breaking! The US and Israel jointly bombed Iran. What will be the stock market trend next week?
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

- No more -